News in brief: Diabetes drug slows Alzheimer’s disease-related cognitive impairment; Lower stroke risk with DOACs vs warfarin for NVAF patients; Neurosurgeon faces urgent disciplinary hearing

Neurosurgeon faces urgent disciplinary hearing UPDATE: Since this article was published, AHPRA has announced details of restrictions on Dr Charlie Teo’s registration. These include a requirement for a statement of support from a Medical Council approved neurosurgeon before performing recurrent malignant intracranial tumour and brain stem tumour surgical procedures. The restrictions also require Dr Teo ...

Already a member?

Login to keep reading.

© 2021 the limbic